The agricultural sector is constantly evolving and as a result the consumers demands keep changing. Continuous innovating is therefore a necessity. Innovation is driven by questions that we receive from our (international) clients in addition to our own questions. We make these innovations effective by delivering reliable and precise data. Since 2003, we develop new technologies with our clients that support the evolving agricultural sector and eventually make this sector more successful.
Product development includes 4 phases: design, characteristics, prototype and market introduction. Botany is the flexible and reliable partner in all phases of product development. Our structured approach and expertise results in an optimal and efficient product development process. This ensures successful introduction of a new product or application into the market. Knowledge and expertise are combined to determine the effectivity and safety of the new products or applications.
Botany has its own R&D facilities. Our indoor facilities include greenhouses, climate cambers and multi-layer growth systems. Outdoor facilities include open field plots and container fields. The setup of the facilities is flexible and if necessary, adaptations can be implement on small (pilot) and large (research) scale.
Reliable and solid experimental setups are accomplished due to our expertise in plant physiology, plant health and cultivation techniques. Our own research facilities and R&D team provide the essential tools and knowhow for product development in the professional agricultural sector. We continue innovations and investments in our research facilities and R&D team. This ensures that our clients lead the way in innovating this sector.
Innexo BV supports better access to cannabis research
Fluence LED has been selected to enable Acceleration Platform for Innovation, a program that helps companies participate in research that advances medical cannabis production in EMEA.Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced an expansion of its research collaboration with Dutch organization Innexo BV (Innexo), a specialist agricultural independent research organization focused on molecular agriculture and medicinal plants.
New director of Botany and Exploras
By the first of January 2023, current director Peter Korsten will be handing over the directorship of Botany and Exploras to his successor Maarten Vliex. In recent years, the Botany Group has grown significantly. The group currently consists of seven different companies, each with its own specialization and managing director. Until recently, Peter Korsten, in addition to being the group managing director of Botany Group, was also managing director of companies Botany and Exploras. This will change on the first of January 2023. On this date he will transfer the directorship to Maarten Vliex.
Innexo BV supports companies innovating in cannabis cultivation through independent research
Since April 1st, Innexo BV is officially licensed by the Dutch Government through the Medical Cannabis Agency to conduct research on cannabis plants for scientific purposes. After a successful audit by the Inspectorate for Healthcare and Youth (IGJ), Innexo is able focus on legal cannabis cultivation research for the next 5 years. Managing Director and co-owner of Innexo, Dominique van Gruisen, is very pleased with this evolution: "This is an important milestone. Not only for the company, but for everybody involved in the medical cannabis industry. We can now help companies that are active in the fields of technological development, genetic exploration, system builders, suppliers and licensed producers, to innovate in cannabis cultivation. More importantly, the research we conduct is practically oriented (applied research) and is independent. We are not producers, we are practically oriented researchers with many years of experience in medicinal plants. Through this license, we can partner with industry leaders to advance the much needed research in the production of cannabis for medical purposes."